Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 5, 2025
A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinomaAda Lerma-Clavero, Maria Kopsida, Nathalie Arendt, et al.
FEBS Open Bio|April 22, 2026
Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signalingAda Lerma-Clavero, Maria Kopsida, Nathalie Arendt, et al.
Plos One|September 3, 2024
Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoidsKarsten Peters, Ada Lerma Clavero, Fredrik Kullenberg, et al.
Lab on a Chip|January 14, 2026
CombiCTx: screening diffusion gradients of anti-cancer drug combinationsChristina Stelzl, Ada Lerma-Clavero, Selina Camenisch, et al.
Drug Delivery and Translational Research|October 12, 2023
Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cellsOliver Degerstedt, Paul O'Callaghan, Ada Lerma Clavero, et al.
Scientific Reports|March 21, 2023
MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxiaAda Lerma Clavero, Paula Lafqvist Boqvist, Katrine Ingelshed, et al.
Molecular Metabolism|November 29, 2023
Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cellsMaria Kopsida, Ada Lerma Clavero, Jaafar Khaled, et al.
Mucosal Immunology|December 21, 2021
Intestinal helminth infection transforms the CD4+ T cell composition of the skinCajsa H Classon, Muzhen Li, Ada Lerma Clavero, et al.
Pageof 1